Creative Medical Technology Holdings, Inc. Increase (Decrease) in Other Operating Liabilities
Creative Medical Technology Holdings, Inc. (CELZ) reported Increase (Decrease) in Other Operating Liabilities of $49.26 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2020-05-15
- Creative Medical Technology Holdings, Inc. increase (decrease) in other operating liabilities for the quarter ending 2020-03-31 was $49.26K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-12-31 was $25.00K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-09-30 was -$65.00K, a 533.33% decline year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other operating liabilities for the quarter ending 2019-06-30 was -$35.00K, a 596.45% decline year-over-year.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other operating liabilities for fiscal 2019 was -$120.00K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other operating liabilities for fiscal 2018 was -$4.67K.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other operating liabilities for fiscal 2017 was -$27.25K, a 109.73% decline from fiscal 2016.
- Creative Medical Technology Holdings, Inc. increase (decrease) in other operating liabilities for fiscal 2016 was $280.00K.
| Period end | Increase (Decrease) in Other Operating Liabilities 0 month | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | $49.26K 10-Q · filed 2020-05-15 | $74.26K derived: sum of 2 quarters · filed 2020-05-15 | $9.26K derived: sum of 3 quarters · filed 2020-05-15 | -$25.74K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | -$40.00K derived: sum of 2 quarters · filed 2020-04-06 | -$75.00K derived: sum of 3 quarters · filed 2020-04-06 | -$120.00K 10-K · filed 2020-04-06 | |
| 2019-09-30 | -$65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$100.00K derived: sum of 2 quarters · filed 2019-11-14 | -$145.00K 10-Q · filed 2019-11-14 | -$215.97K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$80.00K 10-Q · filed 2019-08-13 | -$150.97K derived: sum of 3 quarters · filed 2020-05-15 | -$135.97K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2019-03-31 | -$45.00K 10-Q · filed 2020-05-15 | -$115.97K derived: sum of 2 quarters · filed 2020-05-15 | -$100.97K derived: sum of 3 quarters · filed 2020-05-15 | -$93.92K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | -$70.97K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | -$55.97K derived: sum of 2 quarters · filed 2020-04-06 | -$48.92K derived: sum of 3 quarters · filed 2020-04-06 | -$4.67K 10-K · filed 2020-04-06 | |
| 2018-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $22.05K derived: sum of 2 quarters · filed 2019-11-14 | $66.30K 10-Q · filed 2019-11-14 | $108.55K derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $7.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $51.30K 10-Q · filed 2019-08-13 | $93.55K derived: sum of 3 quarters · filed 2019-08-13 | $11.05K derived: sum of 4 quarters · filed 2019-08-13 | |
| 2018-03-31 | $44.25K 10-Q · filed 2019-05-20 | $86.50K derived: sum of 2 quarters · filed 2019-05-20 | $4.00K derived: sum of 3 quarters · filed 2019-05-20 | $34.50K derived: sum of 4 quarters · filed 2019-05-20 | |
| 2017-12-31 | $42.25K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$40.25K derived: sum of 2 quarters · filed 2019-04-01 | -$9.75K derived: sum of 3 quarters · filed 2019-04-01 | -$27.25K 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$82.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$52.00K derived: sum of 2 quarters · filed 2018-11-14 | -$69.50K 10-Q · filed 2018-11-14 | -$69.50K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $30.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $13.00K 10-Q · filed 2018-08-14 | $13.00K derived: sum of 3 quarters · filed 2018-08-14 | $83.00K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$17.50K 10-Q · filed 2018-08-03 | -$17.50K derived: sum of 2 quarters · filed 2018-08-03 | $52.50K derived: sum of 3 quarters · filed 2018-08-03 | $157.50K derived: sum of 4 quarters · filed 2018-08-03 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $70.00K derived: sum of 2 quarters · filed 2018-03-29 | $175.00K derived: sum of 3 quarters · filed 2018-03-29 | $280.00K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $175.00K derived: sum of 2 quarters · filed 2017-11-13 | $280.00K 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $210.00K 10-Q · filed 2017-08-14 | |||
| 2016-03-31 | $105.00K 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | $100.00 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |